Track topics on Twitter Track topics that are important to you
The demand for testing individuals for genetic disorders or cancers that have arisen from acquired genetic variations is growing year on year. This is being driven by advances in medical genetics where more disorders are being characterised as having causative genetic variations, coupled with the growth in personalised medicine which demands the determination of a patient’s biological characteristics in order to select the most effective therapy regime.
Molecular genetic diagnostics, has been established as a discipline for over three decades, however the underlying technology that is used to deliver tests is still based on a technique developed in 1977 which is both costly and time consuming.
Established through a partnership between the Newcastle Hospitals NHS Foundation Trust and Newcastle University and staffed by renowned experts from each organisation, NewGene is the pioneer in developing, validating and delivering molecular diagnostics using the latest next generation sequencing and genotyping technologies.
The latest high throughput DNA sequencing technologies such as the Roche 454 GS-FLX and Sequenom MALDI-TOF offer significant benefits to molecular diagnostics in terms of a high quality, fast turnaround and lower costs as compared to current established technologies. Whilst these benefits have been realised in the field of genomic research, until recently there has been very little application in molecular diagnostics.
By deploying these technology platforms, NewGene has the capability to handle large volumes of tests ensuring our clients benefit from the economies of scale through competitive pricing and fast turnarounds.
Created in 2008, NewGene has already developed a range of tests for clinically significant inherited disorders and stratified medicine diagnostics for somatic mutations in cancers, delivering services to several UK National Health Service Trusts and overseas healthcare providers. NewGene’s clients are benefiting from a high quality, rapid turnaround service that can be accessed at low cost.
Integrated service provision
With a background in UK NHS molecular genetics, NewGene’s core team understands that healthcare providers need a reliable service that delivers high quality results on time. In addition NewGene understands that providers can have different needs on the basis of their current service and in house expertise. NewGene routinely works with clients to understand their needs in order to offer an optimal service.
Broad portfolio of tests.
Whilst NewGene has a portfolio of important tests that are established on the new technologies and a pipeline of new tests undergoing development, we recognise that healthcare providers need access to a broad range of tests covering a range of disorders. NewGene has partnered with three UK NHS Regional Genetic Laboratories who can offer tests for over 100 inherited disorders. This means that clients can access a broad range of services through NewGene.
In addition to molecular diagnostics NewGene also offers a fast turnaround and cost effective sequencing and genotyping service for researchers.
NewGene’s expanding portfolio of tests includes the following:-
International Centre for Life
Newcastle upon Tyne
Phone: +44 (0)191 242 1923
JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ he...
JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...
JERSEY, Channel Islands, May 17, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today reported that it has completed the verification and validatio...
JERSEY, Channel Islands, July 02, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), has completed the offering of up to $120.0 million ...
JERSEY, Channel Islands, May 29, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt, as its Chief Executi...
VANCOUVER, British Columbia, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has...
Field trial concordance data exceed targeted criteriaPlanned issuance of $36 million in Senior Secured Notes JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QT...
CAMBRIDGE, Mass. and BEIJING, China, July 20, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative...
Famotidine Tablets, USP 20 mg
Facility Maintenance Instant Hand Sanitizer HS-67
Amar ICE GEL
The demand for testing individuals for genetic disorders or cancers that have arisen from acquired genetic variations is growing year on year. This is being driven by advances in medical genet...
Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...
Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...
VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...
We have published hundreds of NewGene Limited news stories on BioPortfolio along with dozens of NewGene Limited Clinical Trials and PubMed Articles about NewGene Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NewGene Limited Companies in our database. You can also find out about relevant NewGene Limited Drugs and Medications on this site too.
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...